Literature DB >> 21214289

Perfusion and permeability MR imaging of gliomas.

M S Shiroishi1, M Habibi, D Rajderkar, C Yurko, J L Go, A Lerner, M A Mogensen, P E Kim, O B Boyko, C-S Zee, M Law.   

Abstract

Conventional contrast-enhanced MR imaging is the current standard technique for the diagnosis and treatment evaluation of gliomas and other brain neoplasms. However, this method is quite limited in its ability to characterize the complex biology of gliomas and so there is a need to develop more quantitative imaging methods. Perfusion and permeability MR imaging are two such techniques that have shown promise in this regard. This review will highlight the underlying principles, applications, and pitfalls of these evolving advanced MRI methods.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21214289     DOI: 10.7785/tcrt.2012.500180

Source DB:  PubMed          Journal:  Technol Cancer Res Treat        ISSN: 1533-0338


  12 in total

1.  High-resolution whole-brain DCE-MRI using constrained reconstruction: Prospective clinical evaluation in brain tumor patients.

Authors:  Yi Guo; R Marc Lebel; Yinghua Zhu; Sajan Goud Lingala; Mark S Shiroishi; Meng Law; Krishna Nayak
Journal:  Med Phys       Date:  2016-05       Impact factor: 4.071

2.  Direct estimation of tracer-kinetic parameter maps from highly undersampled brain dynamic contrast enhanced MRI.

Authors:  Yi Guo; Sajan Goud Lingala; Yinghua Zhu; R Marc Lebel; Krishna S Nayak
Journal:  Magn Reson Med       Date:  2016-11-17       Impact factor: 4.668

Review 3.  Advanced Imaging of Intracranial Meningiomas.

Authors:  Benita Tamrazi; Mark S Shiroishi; Chia-Shang J Liu
Journal:  Neurosurg Clin N Am       Date:  2016-02-18       Impact factor: 2.509

Review 4.  Perfusion MRI: the five most frequently asked technical questions.

Authors:  Marco Essig; Mark S Shiroishi; Thanh Binh Nguyen; Marc Saake; James M Provenzale; David Enterline; Nicoletta Anzalone; Arnd Dörfler; Alex Rovira; Max Wintermark; Meng Law
Journal:  AJR Am J Roentgenol       Date:  2013-01       Impact factor: 3.959

5.  The effects of intravoxel contrast agent diffusion on the analysis of DCE-MRI data in realistic tissue domains.

Authors:  Ryan T Woodall; Stephanie L Barnes; David A Hormuth; Anna G Sorace; C Chad Quarles; Thomas E Yankeelov
Journal:  Magn Reson Med       Date:  2017-11-08       Impact factor: 4.668

6.  Prognostic Value of Conventional Magnetic Resonance Imaging for Adult Patients with Brain Tumors.

Authors:  L Klingelhöfer; D Mucha; K Geiger; R Koch; R von Kummer
Journal:  Clin Neuroradiol       Date:  2014-05-15       Impact factor: 3.649

Review 7.  Advanced techniques using contrast media in neuroimaging.

Authors:  Jean-Christophe Ferré; Mark S Shiroishi; Meng Law
Journal:  Magn Reson Imaging Clin N Am       Date:  2012-09-25       Impact factor: 2.266

8.  Advanced neuroimaging in the clinic: critical appraisal of the evidence base.

Authors:  Adam Z Fink; Lisa B Mogil; Michael L Lipton
Journal:  Br J Radiol       Date:  2016-05-05       Impact factor: 3.039

Review 9.  Perfusion MRI: the five most frequently asked clinical questions.

Authors:  Marco Essig; Thanh Binh Nguyen; Mark S Shiroishi; Marc Saake; James M Provenzale; David S Enterline; Nicoletta Anzalone; Arnd Dörfler; Àlex Rovira; Max Wintermark; Meng Law
Journal:  AJR Am J Roentgenol       Date:  2013-09       Impact factor: 3.959

10.  Imaging practice in low-grade gliomas among European specialized centers and proposal for a minimum core of imaging.

Authors:  Christian F Freyschlag; Sandro M Krieg; Johannes Kerschbaumer; Daniel Pinggera; Marie-Therese Forster; Dominik Cordier; Marco Rossi; Gabriele Miceli; Alexandre Roux; Andrés Reyes; Silvio Sarubbo; Anja Smits; Joanna Sierpowska; Pierre A Robe; Geert-Jan Rutten; Thomas Santarius; Tomasz Matys; Marc Zanello; Fabien Almairac; Lydiane Mondot; Asgeir S Jakola; Maria Zetterling; Adrià Rofes; Gord von Campe; Remy Guillevin; Daniele Bagatto; Vincent Lubrano; Marion Rapp; John Goodden; Philip C De Witt Hamer; Johan Pallud; Lorenzo Bello; Claudius Thomé; Hugues Duffau; Emmanuel Mandonnet
Journal:  J Neurooncol       Date:  2018-07-10       Impact factor: 4.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.